Cited by 228Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingAutophagy in Disease and Therapy

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation

Open access

Malagelada, Cristina, Jin, Zong Hao, Greene, Lloyd A.·2008·The Journal of Neuroscience

DOI 10.1523/jneurosci.3928-08.2008PMC PMC3865436

Open this paper in CoChat — free account Open PDF

Abstract

Previously, we reported that RTP801, a stress regulated protein, is induced in multiple cellular models of Parkinson's disease (PD), in an animal model of PD and in dopaminergic neurons of PD patients. In cellular PD models, RTP801 is both sufficient and necessary for death. We further showed that RTP801 and PD mimetics such as 6-OHDA trigger neuron death by suppressing activation of the key kinase mammalian target of rapamycin (mTOR). Here, we report that as a consequence of mTOR signaling blockade, 6-OHDA suppresses the phosphorylation and activation of Akt, a major supporter of neuron survival. This effect is mediated by RTP801 and appears to underlie neuron death induced by 6-OHDA. Examination of postmortem dopaminergic neurons reveals a consistent depletion of phospho-Akt, but not of total Akt in PD patients. These observations support a sequential mechanism in which PD-associated stresses induce RTP801, suppress mTOR signaling, deplete phosphorylated/activated Akt and permit neuron degeneration and death.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3928-08.2008

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
Greene, L., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,566
Self-citation
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,097

Show all 50 references

Research works printed but not linked: 2

1997, Histol Histopathol, 12, 25
2006, Soc Neurosci Abstr, 32, 221

Sorted by citations

Items 101–200 of 228

Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity
Xing, B., Xin, T., Zhao, L., Hunter, R. L., Chen, Y., & Bing, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.010 · Cited by 37
Protein Kinases and Parkinson’s Disease
Mehdi, S. J., Rosas-Hernández, H., Cuevas, E., Lantz, S. M., Barger, S. W., Sarkar, S., Paule, M. G., Ali, S. F., & Imam, S. Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091585 · Cited by 39
Metabolic aspects of neuronal degeneration: From a NAD+ point of view
Sasaki, Y. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.07.001 · Cited by 39
Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson’s Disease Animal Model
Ferreira, A. F. F., Singulani, M. P., Ulrich, H., Feng, Z., Sun, H., & Britto, L. R. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02723-8 · Cited by 36
Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling
El‐Sayed, R. M., Abdelaziz, A. M., Zaki, H. F., & Rasheed, N. O. A. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109986 · Cited by 36
Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
Morin, N., & Paolo, T. D. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00144 · Cited by 36
Genetic dissection reveals that Akt is the critical kinase downstream of LRRK2 to phosphorylate and inhibit FOXO1, and promotes neuron survival
Chuang, C.-L., Lu, Y., Wang, H.-C., & Chang, H.-Y. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu281 · Cited by 35
The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy
Miller, W. P., Sunilkumar, S., & Dennis, M. D. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.041 · Cited by 35
Expression changes of genes associated with apoptosis and survival processes in Parkinson’s disease
Yalçınkaya, N., Haytural, H., Bılgıç, B., Özdemir, Ö., Hanagasi, H. A., Küçükali, C. İ., Özbek, Z., Akcan, U., Idrısoğlu, H. A., Gurvit, H. I., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.029 · Cited by 35
LIN28A enhances the therapeutic potential of cultured neural stem cells in a Parkinson’s disease model
Rhee, Y., Kim, T., Jo, A. Y., Chang, M., Park, C., Kim, S.-M., Song, J., Oh, S., Yi, S., Kim, H. H., et al. (2016) · Brain · doi:10.1093/brain/aww203 · Cited by 35
Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
Payne, T., Sassani, M., Buckley, E. E., Moll, S., Anton, A., Appleby, M., Maru, S., Taylor, R. N., McNeill, A., Hoggard, N., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038911 · Cited by 34
TORC2: a novel target for treating age-associated memory impairment
Johnson, J. L., Huang, W., Roman, G., & Costa‐Mattioli, M. (2015) · Scientific Reports · doi:10.1038/srep15193 · Cited by 31
Role of IGF-1 in neuroinflammation and cognition deficits induced by sleep deprivation
Wan, Y., Gao, W., Zhou, K., Liu, X., Jiang, W., Xue, R., & Wu, W. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136575 · Cited by 36
Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson’s disease
Braithwaite, S. P., Voronkov, M. V., Stock, J. B., & Mouradian, M. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.031 · Cited by 32
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies
Prakash, S., & Carter, W. G. (2021) · Brain Sciences · doi:10.3390/brainsci11121573 · Cited by 34
Regulation of autophagic flux by CHIP
Guo, D., Ying, Z., Wang, H., Chen, D., Gao, F., Ren, H., & Wang, G. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1543-7 · Cited by 31
Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs
Santini, E., & Klann, E. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00076 · Cited by 34
Association of RAGE gene polymorphisms with sporadic Parkinson's disease in Chinese Han population
Gao, J., Teng, J., Liu, H., Han, X., Chen, B., & Xie, A. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.11.038 · Cited by 31
Nigral dopaminergic PAK4 prevents neurodegeneration in rat models of Parkinson’s disease
Won, S.-Y., Park, M.-H., You, S.-T., Choi, S.-W., Kim, H. K., McLean, C., Bae, S., Kim, S. R., Jin, B. K., Lee, K. H., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1629 · Cited by 31
Loss of NEDD4 contributes to RTP801 elevation and neuron toxicity: implications for Parkinson's disease
Canal, M., Martín‐Flores, N., Pérez‐Sisqués, L., Romaní-Aumedes, J., Altas, B., Man, H., Kawabe, H., Alberch, J., & Malagelada, C. (2016) · Oncotarget · doi:10.18632/oncotarget.11020 · Cited by 30
Self-citation
RTP801 Gene Expression Is Differentially Upregulated in Retinopathy and Is Silenced by PF-04523655, a 19-Mer siRNA Directed Against RTP801
Rittenhouse, K. D., Johnson, T. R., Vicini, P., Hirakawa, B. P., Kalabat, D. Y., Yang, A. H., Huang, W., & Basile, A. S. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13449 · Cited by 30
Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients
Fernández, B., Ferrer, I., Gil, F., & Hilfiker, S. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.03.005 · Cited by 29
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium
Guttuso, T. J., Andrzejewski, K. L., Lichter, D. G., & Andersen, J. K. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.05.016 · Cited by 29
Chronic rapamycin treatment or lack ofS6K1does not reduce ribosome activity in vivo
Garelick, M. G., MacKay, V. L., Yanagida, A., Academia, E. C., Schreiber, K. H., Ladiges, W., & Kennedy, B. K. (2013) · Cell Cycle · doi:10.4161/cc.25512 · Cited by 28
Oncogenic Pathways in Neurodegenerative Diseases
Varela, L., & García-Rendueles, M. E. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063223 · Cited by 30
Recent research progress on metabolic syndrome and risk of Parkinson’s disease
Li, L., Liu, S., Zhuang, J.-L., Li, M.-M., Huang, Z., Chen, Y., Chen, X., Chen, C., Lin, S., & Ye, L. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0093 · Cited by 30
Paraquat and Parkinson’s Disease: The Molecular Crosstalk of Upstream Signal Transduction Pathways Leading to Apoptosis
See, W. Z. C., Naidu, R., & Tang, K. S. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230126161524 · Cited by 27
Maintenance of the self-renewal properties of neural progenitor cells cultured in three-dimensional collagen scaffolds by the REDD1-mTOR signal pathway
Han, J., Xiao, Z., Chen, L., Chen, B., Li, X., Han, S., Zhao, Y., & Dai, J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.063 · Cited by 27
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Fernández‐Santiago, R., Martín‐Flores, N., Antonelli, F., Cerquera‐Cleves, C., Moreno, V., Bandrés‐Ciga, S., Manduchi, E., Tolosa, E. S., Singleton, A., Moore, J. H., et al. (2019) · Movement Disorders · doi:10.1002/mds.27770 · Cited by 27
Self-citation
RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride
del Olmo‐Aguado, S., Núñez‐Álvarez, C., Ji, D., Manso, A. G., & Osborne, N. N. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.08.002 · Cited by 26
Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling
Kim, S. R., Ries, V., Cheng, H., Kareva, T., Oo, T. F., Yu, W. H., Duff, K., Kholodilov, N. G., & Burke, R. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.003 · Cited by 26
Ghrelin protects retinal ganglion cells against rotenone via inhibiting apoptosis, restoring mitochondrial function, and activating AKT-mTOR signaling.
Liu, S.-W., Chen, S., Ren, J., Li, B.-J., & Qin, B. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.11.007 · Cited by 24
Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model
Tasaki, Y., Yamamoto, J., Omura, T., Sakaguchi, T., Kimura, N., Ohtaki, K., Ono, T., Suno, M., Asari, M., Ohkubo, T., et al. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.045 · Cited by 25
RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death
Martín‐Flores, N., Romaní-Aumedes, J., Rué, L., Canal, M., Sanders, P., Straccia, M., Allen, N. D., Alberch, J., Canals, J. M., Pérez‐Navarro, E., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9166-6 · Cited by 29
Self-citation
Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
Mencke, P., Hanss, Z., Boussaad, I., Sugier, P., Elbaz, A., & Krüger, R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00898 · Cited by 25
Diabetes, Insulin and Alzheimer's Disease
Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24
Ginsenoside Rg1 ameliorates stress-exacerbated Parkinson’s disease in mice by eliminating RTP801 and α-synuclein autophagic degradation obstacle
Wang, S., Peng, Y., Fan, P., Ye, J.-R., Ma, W.-Y., Wu, Q.-L., Wang, H., Tian, Y., He, W., Xu, Y., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01374-w · Cited by 23
Early Serum Metabolism Profile of Post-operative Delirium in Elderly Patients Following Cardiac Surgery With Cardiopulmonary Bypass
Huang, H., Han, J., Li, Y., Yang, Y., Shen, J., Fu, Q., & Chen, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.857902 · Cited by 23
Erythropoietin attenuates 6-hydroxydopamine-induced apoptosis via glycogen synthase kinase 3β-mediated mitochondrial translocation of Bax in PC12 cells
Ge, X., Zhu, G., Geng, D., Zhang, Z., & Liu, C. (2012) · Neurological Sciences · doi:10.1007/s10072-012-0959-3 · Cited by 23
Age-dependent changes in the protein expression levels of Redd1 and mTOR in the gerbil hippocampus during normal aging
Choi, H.-S., Ahn, J. H., Park, J. H., Won, M., & Lee, C. H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4835 · Cited by 25
Synaptic RTP801 contributes to motor-learning dysfunction in Huntington’s disease
Martín‐Flores, N., Pérez‐Sisqués, L., Creus‐Muncunill, J., Masana, M., Ginés, S., Alberch, J., Pérez‐Navarro, E., & Malagelada, C. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02775-5 · Cited by 22
Self-citation
Cellular, Molecular and Biochemical Impacts of Silver Nanoparticles on Rat Cerebellar Cortex
Mohamed, E. M., Kattaia, A. A. A., Abdul‐Maksoud, R. S., & El-Baset, S. A. A. (2020) · Cells · doi:10.3390/cells10010007 · Cited by 22
NOX2-Derived Hydrogen Peroxide Impedes the AMPK/Akt-mTOR Signaling Pathway in Parkinson's Disease in Vitro Models
Zhang, R., Liu, C., Liu, Y., Ji, T., Zhang, N., Dong, X., Chen, X., Ma, J., Gao, W., Huang, S., et al. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110330 · Cited by 23
Intracellular signalling pathways in dopamine cell death and axonal degeneration
Burke, R. E. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83005-5 · Cited by 22
The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
McClements, L., Annett, S., Yakkundi, A., & Robson, T. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150519115729 · Cited by 22
Amauroderma rugosum Protects PC12 Cells against 6‐OHDA‐Induced Neurotoxicity through Antioxidant and Antiapoptotic Effects
Li, J., Li, R., Wu, X., Hoo, R. L. C., Lee, S. M., Cheung, T. M., Ho, B. S.-Y., & Leung, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6683270 · Cited by 21
ATP8B2-Mediated Asymmetric Distribution of Plasmalogens Regulates Plasmalogen Homeostasis and Plays a Role in Intracellular Signaling
Honsho, M., Mawatari, S., & Fujiki, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.915457 · Cited by 21
Effect of a chronic treatment with 17β-estradiol on striatal dopamine neurotransmission and the Akt/GSK3 signaling pathway in the brain of ovariectomized monkeys
Sanchez, M. G. D. B., Morissette, M., & Paolo, T. D. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.06.012 · Cited by 21
Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities
Faizan, M., Sarkar, A., & Singh, M. P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101727 · Cited by 22
Genetic Interactions within Inositol-Related Pathways are Associated with Longitudinal Changes in Ventricle Size
Koran, M. E. I., Initiative, A. D. N., Hohman, T. J., Meda, S. A., & Thornton‐Wells, T. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130989 · Cited by 20
Regulation of AKT/AMPK signaling, autophagy and mitigation of apoptosis in Rutin-pretreated SH-SY5Y cells exposed to MPP+
Enogieru, A. B., Haylett, W. L., Hiss, D. C., & Ekpo, O. E. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00641-z · Cited by 20
A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson’s Disease
Ardashov, O. V., Павлова, А. В., Mahato, A. K., Sidorova, Y. A., Morozova, E. A., Викторовна, К. Д., Salnikov, G. E., Genaev, A. M., Patrusheva, O. S., Li-Zhulanov, N. S., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00396 · Cited by 18
Systems Biology of Parkinson's Disease
Wellstead, P. E., & Cloutier, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3411-5 · Cited by 17
Neurotrophic Effects of Serum- and Glucocorticoid-Inducible Kinase on Adult Murine Mesencephalic Dopamine Neurons
Chen, X. M., Tagliaferro, P. A., Kareva, T., Yarygina, O., Kholodilov, N. G., & Burke, R. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5910-11.2012 · Cited by 16
Genetic studies of the protein kinase AKT1 in Parkinson's disease
Ran, C., Westerlund, M., Anvret, A., Willows, T., Sydow, O., Galter, D., & Belin, A. C. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.06.038 · Cited by 16
The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson’s disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway
Kambey, P. A., Ma, C., Xiaoxiao, G., Ayanlaja, A. A., Kanwore, K., Nadeem, I., Wu, J., & Gao, D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00670-2 · Cited by 16
Repurposing GLP-1 Receptor Agonists for Parkinson’s Disease: Current Evidence and Future Opportunities
Victorino, D. B., Nejm, M. B., Guimarães‐Marques, M., Scorza, F. A., & Scorza, C. A. (2021) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00374-5 · Cited by 15
Anti-Parkinsonian effect of Mucuna pruriens and Ursolic acid on GSK3β/Calcium signaling in neuroprotection against Rotenone-induced Parkinsonism
Zahra, W., Birla, H., Singh, S. S., Rathore, A. S., Dilnashin, H., Singh, R., Keshri, P. K., Singh, S., & Singh, S. P. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2022.100343 · Cited by 14
REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment
Yi, J. H., Kwon, H., Cho, E., Jeon, J., Lee, J., Lee, Y. C., Cho, J. H., Jun, M., Moon, M., Ryu, J. H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249482 · Cited by 14
Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson’s Disease
Tan, Y., Ke, M., Huang, Z., Chong, C., Cen, X., Lu, J., Yao, X., Qin, D., & Su, H. (2019) · Aging and Disease · doi:10.14336/ad.2018.1216 · Cited by 14
Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium
Xu, C., Zhang, H., Liu, C., Zhu, Y., Wang, X., Gao, W., Huang, S., & Chen, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4087 · Cited by 12
Periplaneta americana L. extract exerts neuroprotective effects by inhibiting endoplasmic reticulum stress via AKT-dependent pathway in experimental models of Parkinson’s disease
Cao, T., Wang, X., Rao, J., Hui-feng, Z., Qi, H., & Tian, Z. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01029-2 · Cited by 11
RTP801/REDD1 Is Involved in Neuroinflammation and Modulates Cognitive Dysfunction in Huntington’s Disease
Pérez‐Sisqués, L., Solana‐Balaguer, J., Campoy‐Campos, G., Martín‐Flores, N., Sancho‐Balsells, A., Vives-Isern, M., Soler-Palazón, F., García-Forn, M., Masana, M., Alberch, J., et al. (2021) · Biomolecules · doi:10.3390/biom12010034 · Cited by 11
Self-citation
Ginkgolide B Protects Neurons from Ischemic Injury by Inhibiting the Expression of RTP801
Wu, X., Su, J., Chen, L., Ma, B., Gu, X., & Zhu, L. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0189-3 · Cited by 11
Network pharmacology combined with experimental validation show that apigenin as the active ingredient of Campsis grandiflora flower against Parkinson’s disease by inhibiting the PI3K/AKT/NF-κB pathway
Liu, K., An, J., Zhang, J., Zhao, J., Sun, P., & He, Z. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311824 · Cited by 9
The Gut Microflora and its Metabolites Regulate the Molecular Crosstalk between Diabetes and Neurodegeneration
Lomis, S. W. N. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000577 · Cited by 9
Dysregulation of the leukotriene pathway in Parkinson's disease: The potential role of montelukast
Alshahrani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Shokr, M. M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157010 · Cited by 8
Tinospora cordifolia: a potential neuroprotective agent against various neurodegenerative diseases
Singh, R., Bhattacharyya, C., Prashar, V., Arora, T., Sharma, A., Changotra, H., & Parkash, J. (2023) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2023.100775 · Cited by 8
RTP801 mediates transneuronal toxicity in culture via extracellular vesicles
Solana‐Balaguer, J., Martín‐Flores, N., Garcia‐Segura, P., Campoy‐Campos, G., Pérez‐Sisqués, L., Chicote‐González, A., Fernández‐Irigoyen, J., Santamaría, E., Pérez‐Navarro, E., Alberch, J., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12378 · Cited by 8
Self-citation
Impact of Neuro-Behçet Disease Immunoglobulin G on Neuronal Apoptosis
Giriş, M., Bireller, S., Küçükali, C. İ., Hanağası, H. A., Değirmencioğlu, S., & Tüzün, E. (2016) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.19421 · Cited by 8
Association of AKT1 gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population
Li, X., Teng, J., Liu, Y., Wu, Y., Zheng, Y., & Xie, A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.06.052 · Cited by 8
Elevated RTP801 promotes cell proliferation in non‐small cell lung cancer
Su, J., Huang, H., Ju, S., & Shi, J. (2018) · IUBMB Life · doi:10.1002/iub.1727 · Cited by 8
Increased REDD1 facilitates neuronal damage after subarachnoid hemorrhage
Su, J., Wang, M., Yan, Y., Ju, S., Chen, J., & Wu, X. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.019 · Cited by 8
MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell–derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling
Gao, J., Kang, X., Sun, S., Li, L., & Gao, D. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01416-7 · Cited by 8
WITHDRAWN: Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice
Liu, K., Liu, C., Shen, L., Shi, J., Zhang, T., Zhou, Y., Zhou, L., & Sun, X. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.011 · Cited by 7
Context-dependent expression of a conditionally-inducible form of active Akt
Park, S., Burke, R. E., Kareva, T., Kholodilov, N. G., Aimé, P., Franke, T. F., Levy, O., & Greene, L. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197899 · Cited by 7
Self-citation
Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases
Nam, Y., Moon, G. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063064 · Cited by 7
RTP801 regulates motor cortex synaptic transmission and learning
Pérez‐Sisqués, L., Martín‐Flores, N., Masana, M., Solana‐Balaguer, J., Rosell, A. L., Romaní-Aumedes, J., Canal, M., Campoy‐Campos, G., García-García, E., Sánchez-Fernández, N., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113755 · Cited by 8
Self-citation
RTP801 Regulates Maneb‐ and Mancozeb‐Induced Cytotoxicity via NF‐κB
Cheng, S., Oh, S., Velasco, M., Ta, C., Montalvo, J., & Calderone, A. (2014) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21566 · Cited by 7
LncRNA FTX Involves in the Nogo-66-Induced Inhibition of Neurite Outgrowth Through Regulating PDK1/PKB/GSK-3β Pathway
Zuo, Y., Sun, H., Song, L., Hu, Y. L., & Guo, F. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00803-8 · Cited by 7
GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppressionPreprint
Athauda, D. S., Evans, J. R., Mahoney‐Sanchez, L., Virdi, G. S., Lopez-Garcia, P., Wernick, A. I., Wagen, A. Z., D’Sa, K., Lachica, J., Strohbuecker, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.28.582460 · Cited by 7
Parkinson’s disease and brain insulin signaling: Mechanisms and potential role of GLP-1 mimetics
Foroozanmehr, B., Hemmati, M. A., Yaribeygi, H., Karav, S., Jamialahmadi, T., & Sahebkar, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149738 · Cited by 6
Chronic Expression of Interleukin-10 Transgene Modulates Cardiac Sympathetic Ganglion Resulting in Reduced Ventricular Arrhythmia
Li, R., Zhang, L., Peng, C., Lu, Y., Liu, Z., Xu, X., Wang, C., Hu, R., Tan, W., Zhou, L., et al. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.160 · Cited by 6
Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse model
Chicote‐González, A., Solana‐Balaguer, J., Garcia‐Segura, P., Campoy‐Campos, G., Pérez, I. P., Pérez‐Navarro, E., Rodríguez, M. J., Alberch, J., Giralt, A., Sòria, G., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70051 · Cited by 7
Self-citation
Emerging Roles of Signal Transduction Pathways in Neurodegenerative Diseases. Hunting New Possible Therapeutic Molecular Targets
Vasco, V. R. L. (2023) · OBM Geriatrics · doi:10.21926/obm.geriatr.2302234 · Cited by 6
Effects and Mechanisms of Rapamycin Action on Experimental Neurodegeneration
Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2018) · Neurochemical Journal · doi:10.1134/s1819712418030108 · Cited by 6
The genetics of Parkinson’s disease: review of current and emerging candidates
Belin, A. C., & Ran, C. (2014) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s38954 · Cited by 6
Expression pattern of ataxia telangiectasia mutated (ATM), p53, Akt, and glycogen synthase kinase‐3β in the striatum of rats treated with 3‐nitropropionic acid
Duran‐Vilaregut, J., Manich, G., del Valle, J., Camins, A., Pallàs, M., Vilaplana, J., & Pelegrı́, C. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23060 · Cited by 5
RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease
Campoy‐Campos, G., Solana‐Balaguer, J., Guisado-Corcoll, A., Chicote‐González, A., Garcia‐Segura, P., Pérez‐Sisqués, L., Torres, A. G., Canal, M., Molina‐Porcel, L., Fernández‐Irigoyen, J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae776 · Cited by 4
Self-citation
Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
LiuNan, K., Sun, S., & Sun, T. (2013) · Cited by 4
Exploring the link between estimated glucose disposal rate and Parkinson’s disease: cross-sectional and mortality analysis of NHANES 2003–2016
Li, X., & Zeng, Z. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1548020 · Cited by 4
MPTP and rotenone cause dopaminergic neuronal death by increasing DDIT4 promoter lactylation
Hong, J.-C., Yang, Y.-S., He, S.-H., Huang, J.-J., Zhang, X.-R., Zeng, F.-F., Tan, J.-Q., Han, H.-L., & Zhang, Z. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01748-2 · Cited by 3
Narrative Review “Dual Frontiers in Neurodegeneration: Pharmacological Synergies and Divergences in Parkinson’s Disease and Type 2 Diabetes Mellitus”
Sharallah, O. A., Malakar, V. K., Salama, A. E., Elmaaz, S. M., Daba, S. A., & Poddar, N. K. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01702-0 · Cited by 3
Emerging targets signaling for inflammation in Parkinson’s disease drug discovery
Khairnar, R. C., Parihar, N., Prabhavalkar, K. S., & Bhatt, L. K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00999-2 · Cited by 4
Exploring the neuroprotective potential of immunosuppressants in Parkinson's disease
Mubarak, H., Racette, B. A., Killion, J. A., Faust, I. M., Laurido-Soto, O., Doddamreddy, S. A., & Nielsen, S. S. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.107294 · Cited by 4
A Repulsive Environment Induces Neurodegeneration of Midbrain Dopaminergic Neurons
Santiago-Lopez, A. J. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3070-17.2017 · Cited by 3
Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
Garrido, A., Pérez‐Sisqués, L., Simonet, C., Campoy‐Campos, G., Solana‐Balaguer, J., Martín‐Flores, N., Fernández, M., Soto, M., Obiang, D., Cámara, A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26469 · Cited by 2
Self-citation
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management
Abu‐Baih, D. H., El‐Mordy, F. M. A., Saber, E. A., Ali, S. F. E., Hisham, M., Alanazi, M. A., Altemani, F. H., Algehainy, N. A., Lehmann, L., & Abdelmohsen, U. R. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400418 · Cited by 2
Downregulation of AKT-mediated p27Kip1 phosphorylation with shift to sphingomyelin synthesis in CLN3 disease
Bilal, F., Soueid, J., Saab, S., Makhoul, N. J., Hamzé, Z., El-Bazzal, L., Makoukji, J., & Boustany, R. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.06.005 · Cited by 2
Comparison of The Expression Levels of PI3K/Akt Pathway Factors in Parkinson’s Disease and Lung Cancer
Şanlı, E., Yalçınkaya, N., & Tüzün, E. (2018) · Experimed · doi:10.26650/experimed.2018.18003 · Cited by 2

Authors: Malagelada, C., Jin, Z. H., & Greene, L. A.
Affiliations: Columbia University (US)
ORCID: Malagelada, Cristina
Greene, Lloyd A.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2008-12-31
Volume: 28
Issue: 53
Pages: 14363-14371
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.3928-08.2008
PMC: PMC3865436
OpenAlex: W2084140068
Cited by: 228
References: 50
Citations by year: 2026: 8 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 15 · 2021: 20 · 2020: 13 · 2019: 17 · 2018: 10 · 2017: 9 · 2016: 19 · 2015: 11 · 2014: 15 · 2013: 13 · 2012: 19
FWCI: 6.80
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 181 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Parkinson's Disease Foundation
National Institutes of Health
National Institute of Neurological Disorders and Stroke (P50NS038370)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: RTP801, Parkinson's disease, dopaminergic neuron death, Akt phosphorylation, mTOR signaling, 6-hydroxydopamine, neurodegeneration, stress response, Akt/mTOR signaling
MeSH terms: Analysis of Variance, Animals, Animals, Newborn, Cells, Cultured, Gene Expression Regulation, Humans, Melanins, Neurons, Parkinson Disease, Phosphorylation, Serine, Substantia Nigra, Sympatholytics, Threonine, Time Factors, Transcription Factors, Transfection, Oxidopamine, Cell Death, Superior Cervical Ganglion, Green Fluorescent Proteins, Oncogene Protein v-akt, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks